Adverse Events Reporting

Reporting suspected adverse reactions is important. Healthcare professionals are asked to report any suspected adverse reaction to the MHRA. Reporting forms and information can be found at:

www.mhra.gov.uk/yellowcard

Any suspected adverse reactions should also be reported to Gilead Sciences Ltd via email to safety_FC@gilead.com or by telephone 01223897500.

Please note that Gilead Medical Information will forward the reports to our Drug Safety and Public Health Department, which in certain circumstances may contact you for more information about a report.

Gilead Sciences Ltd consistently collates and reviews product safety information received from clinical trials and post-marketing activities. The information received is evaluated on an on-going basis ensuring the continuous surveillance of Gilead Sciences Ltd products.

ONC/UK/18-02/NMAR/1080g(1)
Date of preparation: August 2018

This activity is intended for medical Haematology/Oncology specialists, Pathologists, Pharmacists, Nurses and other healthcare professionals involved in the management of CLL/FL. This is a medical education meeting organised and funded by Gilead Sciences Ltd., a science-based pharmaceutical company. This meeting is a medical education programme designed for healthcare professionals based in the UK and the Republic of Ireland only.